Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Defiance Daily Target 2X Long LLY ETF(LLYX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LLYX
11/13/2026: LLYX (3-star) is a STRONG-BUY. BUY for 21 days. Simulated Profits (28.50%). Updated daily EoD!
The Defiance Daily Target 2X Long LLY ETF (LLYX) provides 2x daily leveraged exposure to the performance of Eli Lilly and Company (LLY). Utilizing swap agreements, it allows traders to amplify their bullish convictions on LLY without using margin. Its primary strength lies in its ability to offer high-intensity tactical exposure, but it carries extreme risks, including the significant impact of daily volatility decay and total dependence on a single stock's performance. It is suited only for sophisticated, active traders who monitor their positions daily and understand the mechanics of leveraged products; it is not intended for long-term buy-and-hold investing.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | This fund is designed for short-term tactical trading rather than long-term growth investing. |
| Momentum investor | Strong fit while signal remains positive | The 2x leverage enhances upside potential for momentum traders during periods of strong upward price trends in LLY. |
| Value investor | Weak fit | Leveraged products are antithetical to the long-term, fundamental-focused nature of value investing. |
| Dividend/Income investor | Weak fit | The fund does not provide reliable income and is subject to significant daily volatility decay. |
| Low-risk investor | Weak fit | This product carries extreme risk and is unsuitable for those seeking capital preservation. |
Investor Profile
Ideal Investor Profile
Experienced, risk-tolerant traders who maintain a short-term time horizon and seek to amplify intraday price action in LLY.
Suitability
Not suitable for long-term investors; designed exclusively for tactical, active, short-term positioning.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | The 2x daily leverage amplifies the inherent volatility of Eli Lilly's stock price. |
| Market risk | High | Adverse moves in LLY stock can lead to rapid and significant capital loss. |
| Concentration | High | The fund is concentrated entirely on the performance of a single company, eliminating diversification benefits. |
| Tracking/expense | Medium / high | Daily rebalancing and swap financing costs can erode returns significantly over time. |
| Liquidity | Medium | Lower volumes compared to major indices may lead to slippage during large trades. |
| Business/sector quality | Medium | The fund is entirely dependent on the commercial success and clinical trial outcomes of Eli Lilly. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
Extremely high due to the 2x leverage multiplier applied to an individual stock's daily movement.
Market Risk
Concentrated risk tied specifically to Eli Lilly and the pharmaceutical regulatory environment.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Single stock | Eli Lilly and Company (LLY) — seeks 2x daily return | 100 | This position provides the underlying exposure to LLY stock required to generate the 200% daily leveraged performance objective. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type ETF | Historic Profit 56.78% | Avg. Invested days 35 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 11/13/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.